Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00027976
First received: December 7, 2001
Last updated: August 1, 2013
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: December 2005
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
Publications: